ADMET: An Essential Component in Drug Discovery and Development

Fig 1

Introduction

The development of safe and effective drugs is a complex and resource-intensive process that requires a deep understanding of how a drug interacts with the human body. This process involves several stages, from drug discovery and preclinical testing to clinical trials and regulatory approval. At each stage, one crucial aspect is the evaluation of a drug’s ADME-Tox properties, which stands for Absorption, Distribution, Metabolism, Excretion, and Toxicity.

ADME-Tox properties are essential for assessing the pharmacokinetics (PK) and pharmacodynamics (PD) of a drug candidate. They help researchers and pharmaceutical companies identify potential issues early in the drug development process, ultimately leading to better decision-making and reduced risks of failure.

In this comprehensive overview, we will delve into the various aspects of ADME-Tox, exploring each component in detail, understanding their significance, and recognizing the tools and techniques used for their assessment.

Absorption

Absorption is the process by which a drug enters the bloodstream from its site of administration. It is a critical factor as it directly affects a drug’s bioavailability, which is the fraction of the administered dose that reaches the systemic circulation.

1. Factors Affecting Absorption:

o Route of Administration: Drugs can be administered via various routes such as oral, intravenous, intramuscular, and more. The route chosen significantly impacts absorption.

o Chemical Properties: A drug’s chemical properties, including solubility and lipophilicity, influence its ability to permeate biological membranes.

o Formulation: The formulation of a drug product, such as tablets, capsules, or injections, can affect its absorption rate.

2. Evaluation Methods:

o In vitro Studies: These studies involve using artificial models, such as the Parallel Artificial Membrane Permeability Assay (PAMPA), to assess a drug’s passive permeability.

o In vivo Studies: Animal and human trials are conducted to evaluate a drug’s absorption under physiological conditions.

Distribution

Distribution refers to the dispersion of a drug throughout the body once it enters the bloodstream. Understanding a drug’s distribution is crucial because it affects its concentration at the target site and potential interactions with other tissues.

1. Factors Affecting Distribution:

o Plasma Protein Binding: Drugs can bind to plasma proteins, reducing their distribution to tissues. Highly bound drugs may have a smaller volume of distribution.

o Blood-Brain Barrier (BBB): The BBB restricts the entry of many drugs into the brain, impacting their distribution to the central nervous system.

o Tissue Perfusion: Highly vascularized tissues receive more significant drug distribution.

2. Evaluation Methods:

o In vitro Binding Assays: These assays measure a drug’s affinity for plasma proteins.

Imaging Techniques: Techniques like positron emission tomography (PET) and magnetic resonance imaging (MRI) can visualize a drug’s distribution in living organisms.

Metabolism

Metabolism, often occurring in the liver, is the process by which the body chemically alters drugs to facilitate their elimination. Drug metabolism can convert pharmacologically inactive compounds into active forms, or vice versa.

1. Significance of Metabolism:

o Activation: Some drugs require metabolic activation to become effective.

o Detoxification: Metabolism can convert toxic compounds into less harmful forms for elimination.

o Elimination: Metabolites are often more water-soluble, facilitating their excretion from the body.

2. Cytochrome P450 Enzymes: Cytochrome P450 (CYP) enzymes play a significant role in drug metabolism. Understanding a drug’s interaction with specific CYP enzymes is critical for predicting its metabolism.

Excretion

Excretion is the process by which the body eliminates drugs and their metabolites. It primarily occurs through the kidneys, but other routes, such as feces and breath, can also contribute.

1. Renal Excretion: The kidneys filter drugs from the bloodstream into urine, a process influenced by glomerular filtration, tubular secretion, and reabsorption.

2. Biliary Excretion: Some drugs and metabolites are excreted into bile, which is then eliminated via feces.

3. Pulmonary Excretion: Gaseous anesthetics and volatile substances can be excreted through the lungs.

Toxicity

Toxicity assessment is a critical aspect of ADME-Tox evaluation. It involves determining the potential adverse effects of a drug on living organisms.

1. Types of Toxicity:

o Acute Toxicity: Immediate adverse effects that occur shortly after drug exposure.

o Chronic Toxicity: Long-term adverse effects that develop over time.

o Organ Toxicity: Adverse effects specific to particular organs or systems.

2. Evaluation Methods:

o Animal Studies: Toxicity studies in animals help identify potential adverse effects.

o In vitro Assays: Cell-based assays can provide insights into cytotoxicity and genotoxicity.

o Clinical Trials: Phase I to III clinical trials involve monitoring patients for adverse effects.

Application of ADME-Tox in Drug Development

The incorporation of ADME-Tox evaluation into the drug development process offers several advantages:

1. Early Identification of Issues: ADME-Tox studies help identify potential problems early, reducing late-stage failures and saving resources.

2. Optimization of Drug Candidates: Understanding a drug’s ADME-Tox profile allows for candidate optimization to enhance efficacy and safety.

3. Regulatory Compliance: Regulatory agencies require thorough ADME-Tox assessments as part of the drug approval process.

4. Reduced Risk: By addressing absorption, distribution, metabolism, excretion, and toxicity during development, drug developers can reduce the risk of unexpected adverse effects in humans.

Conclusion

ADME-Tox evaluation is an integral part of modern drug discovery and development. It enables researchers and pharmaceutical companies to make informed decisions, select promising drug candidates, and ensure that drugs are safe and effective for human use. The multidisciplinary nature of ADME-Tox studies, combining chemistry, biology, pharmacology, and toxicology, underscores its importance in advancing healthcare and bringing new therapies to patients worldwide.

Reference :

1. Kassel DB. Applications of high-throughput ADME in drug discovery. Curr Opin Chem Biol. 2004 Jun;8(3):339–45. doi: 10.1016/j.cbpa.2004.04.015.
2. Wang J, Skolnik S. Recent advances in physicochemical and ADMET profiling in drug discovery. Chem Biodivers. 2009 Nov;6(11):1887–99. doi: 10.1002/cbdv.200900117.
3. van de Waterbeemd H. Improving compound quality through in vitro and in silico physicochemical profiling. Chem Biodivers. 2009 Nov;6(11):1760–6. doi: 10.1002/cbdv.200900056. PMID: 19937820.
4. Segall M, Champness E, Obrezanova O, Leeding C. Beyond profiling: using ADMET models to guide decisions. Chem Biodivers. 2009 Nov;6(11):2144–51. doi: 10.1002/cbdv.200900148.
5. Lagorce D, Douguet D, Miteva MA, Villoutreix BO. Computational analysis of calculated physicochemical and ADMET properties of protein-protein interaction inhibitors. Sci Rep. 2017 Apr 11;7:46277. doi: 10.1038/srep46277
6. Miteva MA, Villoutreix BO. Computational Biology and Chemistry in MTi: Emphasis on the Prediction of Some ADMET Properties. Mol Inform. 2017 Oct;36(10). doi: 10.1002/minf.201700008. Epub 2017 Feb 21.
7. Jónsdóttir SO, Jørgensen FS, Brunak S. Prediction methods and databases within chemoinformatics: emphasis on drugs and drug candidates. Bioinformatics. 2005 May 15;21(10):2145–60. doi: 10.1093/bioinformatics/bti314. Epub 2005 Feb 15
8. Wawer M, Lounkine E, Wassermann AM, Bajorath J. Data structures and computational tools for the extraction of SAR information from large compound sets. Drug Discov Today. 2010 Aug;15(15–16):630–9. doi: 10.1016/j.drudis.2010.06.004. Epub 2010 Jun 12.

Source Code: https://github.com/santuchal/ADMET.git

Streamlit Link : https://hav8whwegtyvgwjixnhxqw.streamlit.app/